best digital health platforms with glp-1 coverage options 7 Telehealth Platforms Changing How We Access GLP-1s GLP-1s and Obesity Coverage: Differing
Description
doi: 10.1016/j.ebiom.2024.105284

So, even though theyve been off their medicine for a month, they restart at the highest dose theyve taken without checking in with their prescribing provider first

It only means that the FDA wants more definitive long-term data
The terms are written into the contract

But some patients have a fear of needles or would prefer to take a pill out of convenience

Retrospective database studies suggest that adherence and persistence rates with once-weekly injectable GLP-1 receptor agonists are better than those achieved with more frequently dosed treatments (5356)